Frequently Asked Questions

Q: Why is it important for me to complete and return the Patient Authorization Form?

A: Without your authorization, the SUPPRELIN LA Support Center cannot assist you in obtaining SUPPRELIN LA for your child. Throughout the process, you can be assured that your information will remain confidential and will only be shared with necessary parties.

Q: What is a specialty pharmacy?

A: A specialty pharmacy is a pharmacy that mails out medications that have complex reimbursement issues. SUPPRELIN LA is an example of a medication you get through a specialty pharmacy. Specialty pharmacies will only mail out SUPPRELIN LA after they receive a prescription from your doctor and have confirmed payment information.

Q: When the SUPPRELIN LA implant leaves the specialty pharmacy, where does it go and how is it delivered?

A: Once you enroll, your SUPPRELIN LA Support Center representative will help arrange with the specialty pharmacy to have the implant delivered directly to the procedure center. You do not have to pick it up and should not have it delivered to your house.

Q: Who do I contact if I have any questions about the SUPPRELIN LA insurance coverage and delivery process?

A: Call the SUPPRELIN LA Support Center toll-free at 1-855-270-0123 if you have any questions about the SUPPRELIN LA insurance coverage and delivery process.

Indication

SUPPRELIN® LA (histrelin acetate) subcutaneous implant is used for the treatment of children with central precocious puberty (CPP).

Important Safety Information

  • SUPPRELIN LA should not be used by women who are or may become pregnant, and in patients who are allergic to gonadotropin releasing hormone (GnRH) or GnRH agonist analogs. Safety and effectiveness in children under 2 years of age has not been determined.

  • SUPPRELIN LA, like other GnRH agonists, may cause a temporary increase in the blood levels of specific hormones associated with the onset of puberty (estrogen in girls and testosterone in both sexes) during the first week of treatment. This increase may temporarily worsen puberty symptoms during the first week, additionally, you may see new symptoms appear during this period. Within the 4 weeks of treatment with SUPPRELIN LA, hormonal suppression generally occurs and the physical signs of puberty should decrease.

  • Your doctor should monitor the levels of specific hormones associated with puberty progression, 1 month after starting SUPPRELIN LA and then every 6 months thereafter. Every 6-12 months, height and bone age should be also monitored by your doctor.

  • During the clinical trial testing of SUPPRELIN LA, the most common side effects involved the implant site and included temporary bruising, pain, soreness, redness of the skin and swelling.

Please talk with your doctor for more information or if you have any questions.